v3.19.3
Stockholders' (Deficit) Equity - Additional Information (Detail) - USD ($)
$ in Millions |
|
|
3 Months Ended |
9 Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
0
|
|
0
|
|
0
|
|
|
| Description of reverse stock split |
|
|
|
|
At BIOLASE’s annual meeting of stockholders on May 9, 2018 (the “2018 Annual Meeting”), BIOLASE stockholders approved an amendment to BIOLASE’s Restated Certificate of Incorporation, as amended, to effect the Reverse Stock Split and on May 10, 2018, the Company filed an amendment (the “Amendment”) to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to effect the Reverse Stock Split, effective as of 11:59 p.m. on May 10, 2018. The Amendment also reduced the authorized shares of common stock from 200,000,000 shares to 40,000,000 shares. Prior year share and per share amounts have been adjusted to reflect the impact of the Reverse Stock Split.
|
|
|
|
|
| Common stock, shares authorized |
|
|
40,000
|
|
40,000
|
|
40,000
|
40,000,000
|
200,000,000
|
| Compensation expense related to stock options |
|
|
$ 0.8
|
$ 0.5
|
$ 1.9
|
$ 1.9
|
|
|
|
| Total unrecognized compensation expense |
|
|
$ 2.3
|
|
$ 2.3
|
|
|
|
|
| Unrecognized share based compensation expense to be recognized over weighted-average period |
|
|
|
|
1 year 8 months 8 days
|
|
|
|
|
| Outstanding stock options, RSUs and warrants excluded from diluted loss per share |
|
|
5,600,000
|
3,200,000
|
5,600,000
|
3,200,000
|
|
|
|
| Restricted Stock Units (RSUs) |
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
| Granted |
|
|
1,900,000
|
|
2,200,000
|
|
|
|
|
| 2002 Stock Incentive Plan |
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
| Common stock authorized for issuance |
|
|
3,100,000
|
|
3,100,000
|
|
|
|
|
| Common stock issued pursuant to options exercised |
|
|
|
|
1,000,000
|
|
|
|
|
| Options and restricted stock units outstanding |
|
|
1,300,000
|
|
1,300,000
|
|
|
|
|
| Options available for future grants |
|
|
0
|
|
0
|
|
|
|
|
| 2018 Long-Term Incentive Plan |
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
| Common stock authorized for issuance |
|
|
5,000,000
|
|
5,000,000
|
|
|
|
|
| Options and restricted stock units outstanding |
|
|
3,900,000
|
|
3,900,000
|
|
|
|
|
| Options available for future grants |
|
|
1,100,000
|
|
1,100,000
|
|
|
|
|
| Subsequent Event |
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance of shares after deducting underwriter discounts and other fees and expenses |
$ 8.4
|
$ 7.8
|
|
|
|
|
|
|
|
| Subsequent Event | Underwritten Public Offering | Common Stock |
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
| Shares issued |
|
7,820,000
|
|
|
|
|
|
|
|
| Subsequent Event | Private Placement | Series E Participating Convertible Preferred Stock |
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
69,695
|
|
|
|
|
|
|
|
| X |
- DefinitionAllocated share-based compensation expense (credit).
| Name: |
biol_AllocatedShareBasedCompensationExpenseCredit |
| Namespace Prefix: |
biol_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
debit |
| Period Type: |
duration |
|
| X |
- DefinitionCommon stock issued pursuant to options exercised.
| Name: |
biol_CommonStockIssuedPursuantToOptionsExercised |
| Namespace Prefix: |
biol_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionProceeds from issuance or sale of equity net.
| Name: |
biol_ProceedsFromIssuanceOrSaleOfEquityNet |
| Namespace Prefix: |
biol_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
debit |
| Period Type: |
duration |
|
| X |
- DefinitionShare based compensation arrangement by share based payment award options and restricted stock units outstanding number.
| Name: |
biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsOutstandingNumber |
| Namespace Prefix: |
biol_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- Definition
+ References
+ Details
| Name: |
biol_StockholdersEquityLineItems |
| Namespace Prefix: |
biol_ |
| Data Type: |
xbrli:stringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
| Name: |
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.
| Name: |
us-gaap_CommonStockSharesAuthorized |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- DefinitionAmount of cost not yet recognized for nonvested award under share-based payment arrangement.
| Name: |
us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
debit |
| Period Type: |
instant |
|
| X |
- DefinitionWeighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
| Name: |
us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:durationItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTotal number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
| Name: |
us-gaap_PreferredStockSharesIssued |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- DefinitionNet number of non-option equity instruments granted to participants.
| Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionNumber of shares authorized for issuance under share-based payment arrangement.
| Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- DefinitionThe difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
| Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- DefinitionNumber of new stock issued during the period.
| Name: |
us-gaap_StockIssuedDuringPeriodSharesNewIssues |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionDescription of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.
| Name: |
us-gaap_StockholdersEquityReverseStockSplit |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:stringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Details
| Name: |
us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_PlanNameAxis=biol_TwoThousandTwoStockIncentivePlanMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_PlanNameAxis=biol_TwoThousandEighteenLongTermIncentivePlanMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_SubsidiarySaleOfStockAxis=biol_UnderwrittenPublicOfferingMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=biol_SeriesEParticipatingConvertiblePreferredStockMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
|
